Cargando…
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
The newly-emerging Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe and fatal acute respiratory disease in humans. Despite global efforts, the potential for an associated pandemic in the future cannot be excluded. The development of effective counter-measures is urgent. MERS-...
Autores principales: | Li, Yan, Wan, Yuhua, Liu, Peipei, Zhao, Jincun, Lu, Guangwen, Qi, Jianxun, Wang, Qihui, Lu, Xuancheng, Wu, Ying, Liu, Wenjun, Zhang, Buchang, Yuen, Kwok-Yung, Perlman, Stanley, Gao, George F, Yan, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650419/ https://www.ncbi.nlm.nih.gov/pubmed/26391698 http://dx.doi.org/10.1038/cr.2015.113 |
Ejemplares similares
-
MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016) -
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
por: Yuan, Yuan, et al.
Publicado: (2017) -
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
por: Lu, Guangwen, et al.
Publicado: (2013) -
Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
por: Wang, Qihui, et al.
Publicado: (2014) -
Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein
por: Han, Xue, et al.
Publicado: (2017)